Amisulpride augmentation in clozapine-unresponsive schizophrenia (AMICUS): a double-blind, placebo-controlled, randomised trial of clinical effectiveness and cost-effectiveness
Thomas R. E. Barnes(Unknown), Tim Amos(University of Bristol)
Cited by 38
Related Papers
Relapse Prevention in Schizophrenia With New-Generation Antipsychotics: A Systematic Review and Exploratory Meta-Analysis of Randomized, Controlled Trials
|American Journal of Psychiatry|2003|491
Suicide in mental health in-patients and within 3 months of discharge
|The British Journal of Psychiatry|2006|241